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Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the 
United States, with an overall five year survival rate of 7%. This is partly due to the lack of effective 
models that simulate the complex PDAC tumor microenvironment and allow for high throughput drug 
screening. Some of the key features of the PDAC tumor microenvironment are the presence of a dense 
stroma which impedes effective drug delivery to the pancreatic cancer cells (PCCs), as well as the 
presence of cancer associated fibroblasts (CAFs) that have been shown to modulate disease progression. 
The objective of this project is to develop an in vitro microfluidic cell culture system that allows 
researchers to recapitulate the PDAC tumor environment. The system, Tumor-Microenvironment-on-Chip 
(T-MOC) is manufactured using a replica molding technique. The chip consist of two 
polydimethylsiloxane (PDMS) layers separated by a porous membrane for gas exchange. This device 
forms an enclosed transparent device with input channel for cell entry and inner channels which mimic 
fluidic transport found in vivo. To analyze the potential of the device to simulate in vivo conditions, PCCs 
(GFP+) and CAFs (RFP+) were co-cultured with collagen and inserted into the device. Initial data 
analysis indicates that the device supports the growth of PCCs and allows formation of 3D tumor 
spheroids. In addition, analysis of GFP and RFP intensity demonstrated the effect of CAFs on PCCs 
growth, which diminished PCCs growth. This provides evidence that the microfluidic device can be used 
to replicate tumor environment allowing for future studies to screen potential drug candidates before in 
vivo studies. 
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